Neurocosmetics are the latest in a host of wellness trends to hone in on the link between the topical products we use and our ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

What if I’m doomed to live with this forever? Kendra Johnson thought as she looked in the mirror. The Spokane, Washington, ...

Your indoor versus outdoor environment could have an even bigger impact on your eczema symptoms than you realize.

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get ...

Many people with ongoing medical conditions experience more symptoms during the winter. Here's why, and what you can do.

Associations between therapies and quality of life (QoL) in patients with generalized pustular psoriasis (GPP) can differ substantially.

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.